Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin Glue to Prevent Bleeding After ESD in Gastric Neoplasm
NCT04602689Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2020
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Fibrinogen human in Bleeding peptic ulcer (PUB) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Bleeding after Endoscopic Submucosal Dissection at 4 weeks. Started Oct 2020; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding peptic ulcer (PUB)
Beyond the preview
Go deeper on NCT04602689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04602689.